Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Owens & Minor Inc is a medical distribution business based in the US. Owens-and-Minor shares (OMI) are listed on the NYSE and all prices are listed in US Dollars. Owens-and-Minor employs 18,800 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$33.50|
|52-week range||$13.74 - $49.15|
|50-day moving average||$38.27|
|200-day moving average||$39.07|
|Wall St. target price||$46.17|
|Dividend yield||$0.01 (0.03%)|
|Earnings per share (TTM)||$3.28|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-15)||-6.71%|
|1 month (2021-08-20)||-9.85%|
|3 months (2021-06-22)||-24.33%|
|6 months (2021-03-22)||-11.26%|
|1 year (2020-09-22)||134.27%|
|2 years (2019-09-20)||497.15%|
|3 years (2018-09-21)||95.22%|
|5 years (2016-09-22)||34.6|
Valuing Owens-and-Minor stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Owens-and-Minor's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Owens-and-Minor's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Owens-and-Minor shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Owens-and-Minor's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Owens-and-Minor's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Owens-and-Minor's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $533.7 million.
The EBITDA is a measure of a Owens-and-Minor's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$9.4 billion|
|Operating margin TTM||4.85%|
|Gross profit TTM||$1.3 billion|
|Return on assets TTM||8.43%|
|Return on equity TTM||37.37%|
|Market capitalisation||$2.6 billion|
TTM: trailing 12 months
There are currently 5.4 million Owens-and-Minor shares held short by investors – that's known as Owens-and-Minor's "short interest". This figure is 8.5% up from 5.0 million last month.
There are a few different ways that this level of interest in shorting Owens-and-Minor shares can be evaluated.
Owens-and-Minor's "short interest ratio" (SIR) is the quantity of Owens-and-Minor shares currently shorted divided by the average quantity of Owens-and-Minor shares traded daily (recently around 776525.07204611). Owens-and-Minor's SIR currently stands at 6.94. In other words for every 100,000 Owens-and-Minor shares traded daily on the market, roughly 6940 shares are currently held short.
However Owens-and-Minor's short interest can also be evaluated against the total number of Owens-and-Minor shares, or, against the total number of tradable Owens-and-Minor shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Owens-and-Minor's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Owens-and-Minor shares in existence, roughly 70 shares are currently held short) or 0.0742% of the tradable shares (for every 100,000 tradable Owens-and-Minor shares, roughly 74 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Owens-and-Minor.
Find out more about how you can short Owens-and-Minor stock.
Dividend payout ratio: 0.22% of net profits
Recently Owens-and-Minor has paid out, on average, around 0.22% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.03% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Owens-and-Minor shareholders could enjoy a 0.03% return on their shares, in the form of dividend payments. In Owens-and-Minor's case, that would currently equate to about $0.01 per share.
While Owens-and-Minor's payout ratio might seem low, this can signify that Owens-and-Minor is investing more in its future growth.
Owens-and-Minor's most recent dividend payout was on 29 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 September 2021 (the "ex-dividend date").
Owens-and-Minor's shares were split on a 3:2 basis on 31 March 2010. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Owens-and-Minor shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Owens-and-Minor shares which in turn could have impacted Owens-and-Minor's share price.
Over the last 12 months, Owens-and-Minor's shares have ranged in value from as little as $13.7361 up to $49.154. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Owens-and-Minor's is 0.2227. This would suggest that Owens-and-Minor's shares are less volatile than average (for this exchange).
Owens & Minor, Inc. , together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels.
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
Everything we know about the Wetouch Technology IPO, plus information on how to buy in.
Everything we know about the Life Time Group Holdings IPO, plus information on how to buy in.
Everything we know about the Slinger Bag IPO, plus information on how to buy in.
Everything we know about the NSTS Bancorp IPO, plus information on how to buy in.
Everything we know about the Volcon IPO, plus information on how to buy in.
Everything we know about the Thomas James Homes IPO, plus information on how to buy in.
Everything we know about the FGI Industries IPO, plus information on how to buy in.
Everything we know about the Zhong Yang Financial Group IPO, plus information on how to buy in.
Everything we know about the Exscientia Ltd IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.